Summary & Overview
CPT 64581: Open Sacral Nerve Neurostimulator Electrode Implantation, Transforaminal
CPT code 64581 covers the open implantation of a sacral nerve neurostimulator electrode array via a transforaminal approach. The code is clinically important because sacral neuromodulation is an established surgical option for refractory urinary and fecal incontinence and certain forms of chronic pelvic pain; its use affects surgical workflows, device utilization, and post‑acute care planning nationwide. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise national overview of what the code represents, clinical contexts in which the procedure is performed, typical sites of service, and the payer landscape relevant to reimbursement and prior authorization patterns. The publication also outlines common billing modifiers and operational considerations tied to surgical neuromodulation, highlights benchmarking metrics where available, and notes areas where data were not provided. This summary is intended for health policy analysts, revenue cycle professionals, and clinical leaders seeking a compact reference on CPT code 64581 and its role in neuromodulation services.
Billing Code Overview
CPT code 64581 describes an open implantation of a sacral nerve neurostimulator electrode array using a transforaminal approach (placement through the sacral foramen). This procedure is performed to implant electrodes that stimulate sacral nerves and is commonly used to address conditions such as urinary or fecal incontinence and chronic pelvic pain.
Service type: Surgical implant — neuromodulation/electrophysiology
Typical site of service: Operating room or ambulatory surgery center, with perioperative care occurring in hospital or surgical facility settings depending on patient needs.
Clinical & Coding Specifications
Clinical Context
A 48-year-old patient with refractory overactive bladder and urinary urgency incontinence presents after conservative management (behavioral therapy, pelvic floor rehabilitation, and medications) failed. The urology team evaluates the patient and determines neuromodulation is appropriate. The patient undergoes an open sacral nerve neurostimulator electrode array implantation with transforaminal lead placement (CPT 64581). The procedure is performed in an operating room under general or regional anesthesia. Preoperative workflow includes informed consent, pre-op imaging review, antibiotic prophylaxis per facility protocol, and intraoperative fluoroscopic guidance to localize sacral foramina. The surgeon performs an open approach to expose the sacral foramen, places the electrode array transforaminally along the S3 nerve root, secures leads to soft tissue, tunnels the leads to a generator pocket, and confirms appropriate stimulation parameters. Postoperative workflow includes recovery unit monitoring, pain control, wound care instructions, device programming in follow-up, and coordination with the device representative for activation and troubleshooting. Typical site of service is an ambulatory surgery center or hospital outpatient surgical suite. The service type is operative implantation of a neuromodulation device for management of urinary or fecal incontinence or chronic pelvic pain.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |